<DOC>
	<DOCNO>NCT01899378</DOCNO>
	<brief_summary>Here investigator propose preliminarily investigate safety effect probiotics infant Bangladesh pilot randomize clinical trial . The investigator hypothesize two probiotic safe infant Bangladesh may effect biomarkers gut health immunity . The specific aim pilot : ) confirm safety administer probiotic strain infant low-income country , ii ) determine effect dose frequency colonization persistence probiotic GI tract , iii ) measure marker intestinal immune function microbiota structure .</brief_summary>
	<brief_title>Safety Efficacy Probiotics Bangladeshi Infants</brief_title>
	<detailed_description />
	<mesh_term>Sulfalene</mesh_term>
	<criteria>Healthy infant . Infants 1 3 month age begin study . Parents/guardians subject able understand study procedure agree participate study give consent . Parents child plan remain Dhaka next four month . Infants know birth defect . Infants hospitalize . Infants acute infection illness time enrolment . Infants currently take antibiotic Infants &lt; 1 month age &gt; 3 month age . Infants three standard deviation mean anthropometric measure ( refer medical care ) . Infants already receive probiotic product treatment . A diagnosis suspicion immunodeficiency disorder . A diagnosis suspicion bleed disorder would contraindicate venipuncture . Family residence outside Dhaka family expect move outside Dhaka next 4 month .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>probiotic</keyword>
</DOC>